Trial intelligence / Profile preview

PRP for Post-partum Levator Ani Muscle Trauma

NCT03021954Phase 3Completed

Sponsor
Dr. Cipto Mangunkusumo Hospital
Start
Nov 2016
Primary completion
Jan 2019
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of autologous platelet-rich plasma in levator ani muscle injury (LAMI) (2 arms), sponsored by Dr. Cipto Mangunkusumo Hospital. Primary endpoints: Changes of Levator Hiatal Area During Valsava at 3 months and Changes in Pelvic Floor Muscle Contraction at 3 months. Started Nov 2016; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

levator ani muscle injury (LAMI)

Beyond the preview

Go deeper on NCT03021954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03021954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call